FDA.reportPublic FDA data

mavorixafor 100 MG Oral Capsule

RxCUI
2684026
RxNorm name
mavorixafor 100 MG Oral Capsule
Display name
mavorixafor 100 MG Oral Capsule
Full name
mavorixafor 100 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XOLREMDIMAVORIXAFORX4 Pharmaceuticals, Inc.7f3a5ee3-ca73-4876-85a0-ed1e108a22372024-11-12Warnings, Adverse reactionsExact identifier
rxcui: 2684026

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7f3a5ee3-ca73-4876-85a0-ed1e108a2237mavorixafor 100 MG Oral Capsule [PSN] · mavorixafor 100 MG Oral Capsule [SCD]27These highlights do not include all the information needed to use XOLREMDI™ safely and effectively. See full prescribing information for XOLREMDI ® . XOLREMDI ® (mavorixafor) capsules, for oral use Initial U.S. Approval: 202420241112